Patients with axSpA and early-stage hypertension face elevated risks for CVEs, likely due to their high inflammatory burden.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback